Evidence map›Paper›PMID 36900656›Full record

ArticleHealthcare (Basel, Switzerland)2023

Evaluation, Description and Magnitude of Readmission Phenomenon in Azienda Ospedaliero Universitaria Pisana (AOUP) for Chronic-Degenerative Diseases in the Period 2018-2021.

Matteo Filippi, Erika Del Prete, Ferruccio Aquilini, Michele Totaro, Francesca Di Serafino, Sara Civitelli, Giulia Geminale, David Rocchi, Nunzio Zotti, Angelo Baggiani

Full text read
In one paragraph

Article in Healthcare (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Matteo FilippiThe Azienda Ospedaliero Universitaria Pisana (AOUP), 56100 Pisa, Italy.
Erika Del PreteDepartment of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, 56123 Pisa, Italy.
Ferruccio AquiliniThe Azienda Ospedaliero Universitaria Pisana (AOUP), 56100 Pisa, Italy.
Michele TotaroDepartment of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, 56123 Pisa, Italy.
Francesca Di SerafinoDepartment of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, 56123 Pisa, Italy.
Sara CivitelliDepartment of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, 56123 Pisa, Italy.
Giulia GeminaleDepartment of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, 56123 Pisa, Italy.
David RocchiDepartment of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, 56123 Pisa, Italy.
Nunzio ZottiDepartment of Translational Research and the New Technologies in Medicine and Surgery, University of Pisa, 56123 Pisa, Italy.
Angelo BaggianiThe Azienda Ospedaliero Universitaria Pisana (AOUP), 56100 Pisa, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReadmissions are hospitalizations following a previous hospitalization (called index hospitalization) of the same patient that occurred in the same facility or nursing home. They may be a consequence of the progression of the natural history of a disease, but they may also reveal a previous suboptimal stay, or ineffective management of the underlying clinical condition. Preventing avoidable readmissions has the potential to improve both a patient's quality of life, by avoiding exposure to the risks of re-hospitalization, and the financial well-being of health care systems.

methodsWe investigated the magnitude of 30 day repeat hospitalizations for the same Major Diagnostic Category (MDC) in the Azienda Ospedaliero Universitaria Pisana (AOUP) over the period from 2018 to 2021. Records were divided into only admissions, index admissions and repeated admission. The length of the stay of all groups was compared using analysis of variance and subsequent multi-comparison tests.

resultsResults showed a reduction in readmissions over the period examined (from 5.36% in 2018 to 4.46% in 2021), likely due to reduced access to care during the COVID-19 pandemic. We also observed that readmissions predominantly affect the male sex, older age groups, and patients with medical Diagnosis Related Groups (DRGs). The length of stay of readmissions was longer than that of index hospitalization (difference of 1.57 days, 95% CI 1.36-1.78 days,

conclusionsA patient who goes for readmission thus has an overall hospitalization duration of almost two and a half times the length of the stay of a patient with single hospitalization, considering both index hospitalization and readmission. This represents a heavy use of hospital resources, about 10,200 more inpatient days than single hospitalizations, corresponding to a 30-bed ward working with an occupancy rate of 95%. Knowledge of readmissions is an important piece of information in health planning and a useful tool for monitoring the quality of models of patient care.

Indexed as

chronic diseasescontinuity of careDiagnosis Related Grouphealth economicsreadmissions

Identifiers

PMID36900656
PMCPMC10001156

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read56
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.